PI4K2B Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with PI4K2B Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with PI4K2B Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with PI4K2B Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with PI4K2B Up.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000130724 - charged multivesicular body protein 2A

Gene

ENSG00000186283 - torsin family 3 member A

Gene

ENSG00000114646 - chondroitin sulfate proteoglycan 5

Gene

ENSG00000133019 - cholinergic receptor muscarinic 3

Gene

ENSG00000163064 - engrailed homeobox 1

Gene

ENSG00000205927 - oligodendrocyte transcription factor 2

Gene

ENSG00000111728 - ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1

Gene

ENSG00000103351 - intraflagellar transport 38

  • Gene

    ENSG00000130724 - charged multivesicular body protein 2A


  • Gene

    ENSG00000186283 - torsin family 3 member A


  • Gene

    ENSG00000114646 - chondroitin sulfate proteoglycan 5


  • Gene

    ENSG00000133019 - cholinergic receptor muscarinic 3


  • Gene

    ENSG00000163064 - engrailed homeobox 1


  • Gene

    ENSG00000205927 - oligodendrocyte transcription factor 2


  • Gene

    ENSG00000111728 - ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1


  • Gene

    ENSG00000103351 - intraflagellar transport 38

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.